Joanna Stefanowicz

Dr. Joanna Stefanowicz

Department of Pediatrics, Hematology and Oncology, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland;
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Advances in Dermatology and Allergology
Verified
Journal Article
Open access
PDF file
MJMichalina Jezierska
Michalina Jezierska
JSJoanna Stefanowicz
Joanna Stefanowicz
GRGrzegorz Romanowicz
Grzegorz Romanowicz
WKWojciech Kosiak
Wojciech Kosiak
MLMagdalena Lange
Magdalena Lange
Langerhans cell histiocytosis is a rare clonal disease characterized by the proliferation of CD1a-positive immature dendritic cells. The purpose of this article was to present an updated review of recent advances in the pathogenesis, clinical features, imaging and treatment of this disease. The...

31 July 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
AKALEKSANDRA KACZOROWSKA
ALEKSANDRA KACZOROWSKA
NMNatalia Miękus
Natalia Miękus
JSJoanna Stefanowicz
Joanna Stefanowicz
EAElżbieta Adamkiewicz-Drożyńska
Elżbieta Adamkiewicz-Drożyńska
The tumor microenvironment (TME) consists of numerous biologically relevant elements. One of the most important components of the TME is the extracellular matrix (ECM). The compounds of the ECM create a network that provides structural and biochemical support to surrounding cells. The most important substances involved in the regulation of the ECM degradation process are matrix metalloproteinases (MMPs) and their endogenous inhibitors (tissue inhibitors of metalloproteinases, TIMPs). The disruption of the physiological balance between MMP activation and deactivation could lead to progression of various diseases such as cardiovascular disease, cancer, fibrosis arthritis, chronic tissue ulcers, pathologies of the nervous system (such as stroke and Alzheimer’s disease), periodontitis, and atheroma. MMP-TIMP imbalance results in matrix proteolysis associated with various pathological processes such as tumor invasion. The present review discusses the involvement of two MMPs, MMP-2 and MMP-7, in cancer pathogenesis. These two MMPs have been proven in several studies, conducted mostly on adults, to make an important contribution to cancer development and progression. In the current review, several studies that indicate the importance of MMP-TIMP balance determination for the pediatric population are also highlighted. The authors of this review believe that carrying out biochemical and clinical studies focused on metalloproteinases and their inhibitors in tumors in children will be of great relevance for future patient diagnosis, determination of a prognosis, and monitoring of therapy.

29 January 2011 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
JSJoanna Stefanowicz
Joanna Stefanowicz
MKMateusz Kosiak
Mateusz Kosiak
GRGrzegorz Romanowicz
Grzegorz Romanowicz
RORadosław Owczuk
Radosław Owczuk
EAElżbieta Adamkiewicz-Drożyńska
Elżbieta Adamkiewicz-Drożyńska
ABAnna Balcerska
Anna Balcerska
Glomerular filtration rate (GFR) was evaluated in 32 Wilms’ tumour survivors (WTs) in a cross-sectional study using 99 Tc-diethylene triamine pentaac

2 June 2010 in Clinical & Experimental Metastasis
Verified
Journal Article
Open access
PDF file
EBEwa Bien
Ewa Bien
LMLucyna Maciejka-Kapuscinska
Lucyna Maciejka-Kapuscinska
MNMaciej Niedzwiecki
Maciej Niedzwiecki
JSJoanna Stefanowicz
Joanna Stefanowicz
ASAnna Szolkiewicz
Anna Szolkiewicz
ABAnna Balcerska
Anna Balcerska
The paper presents diagnostic and therapeutic difficulties in two adolescents with widespread rhabdomyosarcoma (RMS) presenting with severe haemorrhages resulting from disseminated intravascular coagulation (DIC) and with laboratory features of acute tumour lysis syndrome (ATLS). Other published cases of childhood RMS with DIC at admission have been listed and reviewed. It has been concluded that the clinical picture of a widespread RMS in children may resemble acute hematologic malignancy and pose a big diagnostic problem. That is why the presence of small blue round cells morphologically similar to lymphoblasts and/or myeloblasts in bone marrow (BM), lacking hematopoietic makers, should prompt the pathologist to consider possible diagnosis of RMS. Inclusion of desmin, MyoD1 and myogenin Myf4 to the immunohistochemical panel is obligatory in such cases. When the representative histopathological tumour specimens are difficult to obtain, the flow cytometric immunophenotyping of BM metastases could help the standard morphological/immunohistological diagnostic procedures and advance the diagnosis. Recently, the flow cytometric CD45− CD56+ immunophenotype together with Myf4 transcript has been assigned to RMS cells infiltrating BM. In children with disseminated RMS complicated with DIC rapid polychemotherapy aimed at diminishing the malignancy-triggered procoagulant activity should be initiated. However, in cases with concomitant ATLS the initial doses of chemotherapy should be reduced and the metabolic disorders and renal function monitored. The prognosis in children with RMS metastatic to BM with signs of DIC or ATLS at admission depends on the response to chemotherapy, however generally it is highly disappointing.

24 July 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
MMMaciej Murawski
Maciej Murawski
MSMonika Scheer
Monika Scheer
ILIvo Leuschner
Ivo Leuschner
JSJoanna Stefanowicz
Joanna Stefanowicz
JBJolanta Bonar
Jolanta Bonar
JFJörg Fuchs
Jörg Fuchs

24 November 2011 in Kidney and Blood Pressure Research
Verified
Journal Article
Open access
PDF file
JSJoanna Stefanowicz
Joanna Stefanowicz
RORadosław Owczuk
Radosław Owczuk
BKBogna Kałużyńska
Bogna Kałużyńska
EAEwa Aleksandrowicz
Ewa Aleksandrowicz
AOAnna Owczarzak
Anna Owczarzak
ABAnna Balcerska
Anna Balcerska
Aims: To test the hypothesis that Wilms tumour survivors (WTs) experience increased disturbance in renal function, even after prompt treatment, compared to patients with unilateral renal agenesis (URA). Methods: To assess the renal function of 30 WTs and 17 individuals with URA, the estimated glomerular filtration rate (eGFR) was calculated using the Schwartz and Filler formulas as well as the new Schwartz equation for chronic kidney disease. To measure kidney damage, serum levels and urine excretion of β2-microglobulin (B2M), cystatin C (Cys C), neutrophil gelatinase-associated lipocalin (NGAL) were tested, N-acetyl-β-glucosaminidase (NAG), and albumin urine excretion and urine sediment were examined. Blood pressure was measured. Results: No differences were found between the groups in terms of eGFR, serum Cys C, B2M and NGAL concentrations. The urine excretion of Cys C, NGAL and NAG was similar in both groups. URA patients had higher B2M excretion than WTs. Arterial hypertension was present in 7/30 (23%) WTs and 1/17 (6%) patients with URA. Conclusions: WTs have similar eGFR to individuals with URA and are more likely to have arterial hypertension. The patients with URA have signs of tubular damage. This study demonstrates the need for nephrological monitoring of individuals with a single kidney.